Early mortality in patients with cancer treated with immunotherapy in routine practice

被引：0
作者：
Raphael, J. [1 ]
Richard, L. [2 ]
Lam, M. [2 ]
Blanchette, P. [3 ]
Leighl, N. [4 ]
Rodrigues, G. [5 ]
Trudeau, M. E. [6 ]
Krzyzanowska, M. K. [7 ]
机构：
[1] London Hlth Sci Ctr LHSC, London Reg Canc Program LRCP, Oncol Dept, London, ON, Canada
[2] Inst Clin Evaluat Sci, Canc Program, Toronto, ON, Canada
[3] London Hlth Sci Ctr LHSC, Dept Med Oncol, London Reg Canc Program LRCP, London, ON, Canada
[4] Princess Margaret Canc Ctr, Med, Toronto, ON, Canada
[5] London Hlth Sci Ctr LHSC, London Reg Canc Program LRCP, Oncol, London, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Med, Toronto, ON, Canada
[7] UHN Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
776P
引用
收藏
页码：S895 / S896
页数：2
相关论文
共 50 条
  • [21] Mortality within 30 days of immunotherapy (checkpoint inhibitors) in metastatic cancer patients treated at Australian tertiary cancer center.
    Mandaliya, Hiren A.
    Kim, Sang
    Quah, Gaik Tin
    Min, Sandy Tun
    Carlton, James
    Faulkner, Jack
    Oldmeadow, Christopher
    Mallesara, Girish
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Machine learning models in the prediction of one-year mortality in patients with advanced hepatocellular cancer treated with immunotherapy
    Lui, Thomas Ka Luen
    Cheung, Michael Ka Shing
    Leung, Wai Keung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 59 - 60
  • [23] Integrating early palliative care into routine practice for patients with cancer: A mixed methods evaluation of the INTEGRATE Project
    Evans, Jenna M.
    Mackinnon, Marnie
    Pereira, Jose
    Earle, Craig C.
    Gagnon, Bruno
    Arthurs, Erin
    Gradin, Sharon
    Buchman, Sandy
    Wright, Frances C.
    PSYCHO-ONCOLOGY, 2019, 28 (06) : 1261 - 1268
  • [24] Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data
    Raphael, Jacques
    Richard, Lucie
    Lam, Melody
    Blanchette, Phillip S.
    Leighl, Natasha B.
    Rodrigues, George
    Trudeau, Maureen E.
    Krzyzanowska, Monika K.
    ONCOLOGIST, 2022, 27 (08) : 675 - 684
  • [25] Treatment sequencing and survival outcomes in BRAF mutation-positive metastatic melanoma patients treated with immunotherapy in routine clinical practice in the United States
    Sadetsky, Natalia
    Chuo, Ching-Yi
    McKenna, Edward
    Troutman, Sarah
    Colburn, Dawn
    Atkins, Michael B.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [26] Patterns of specialty referral in cancer patients treated with immunotherapy regimens
    Chen, Anna
    Dusza, Stephen
    Faleck, David
    Shah, Neil
    Lacouture, Mario E.
    CANCER RESEARCH, 2024, 84 (06)
  • [27] Improved survival for patients with lung cancer treated with perioperative immunotherapy
    Presley, Carolyn J.
    Owen, Dwight H.
    LANCET, 2024, 404 (10459) : 1176 - 1178
  • [28] Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and Challenges
    Pilla, Lorenzo
    Maccalli, Cristina
    BIOMEDICINES, 2018, 6 (03)
  • [29] PILE: a candidate prognostic score in cancer patients treated with immunotherapy
    Guven, D. C.
    Yildirim, H. C.
    Bilgin, E.
    Aktepe, O. H.
    Taban, H.
    Sahin, T. K.
    Cakir, I. Y.
    Akin, S.
    Dizdar, O.
    Aksoy, S.
    Yalcin, S.
    Erman, M.
    Kilickap, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (08) : 1630 - 1636
  • [30] Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy
    Merlano, Marco Carlo
    Abbona, Andrea
    Paccagnella, Matteo
    Falletta, Antonella
    Granetto, Cristina
    Ricci, Vincenzo
    Fea, Elena
    Denaro, Nerina
    Ruatta, Fiorella
    Merlotti, Anna
    Bertetto, Oscar
    Crosetto, Nicola
    Galizia, Danilo
    Basirico, Marco
    Gammaitoni, Loretta
    Sangiolo, Dario
    Aglietta, Massimo
    Garrone, Ornella
    VACCINES, 2021, 9 (03) : 1 - 16
12345